1. Home
  2. RCKT vs AMC Comparison

RCKT vs AMC Comparison

Compare RCKT & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • AMC
  • Stock Information
  • Founded
  • RCKT 1999
  • AMC 1920
  • Country
  • RCKT United States
  • AMC United States
  • Employees
  • RCKT N/A
  • AMC N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • AMC Movies/Entertainment
  • Sector
  • RCKT Health Care
  • AMC Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • AMC Nasdaq
  • Market Cap
  • RCKT 326.4M
  • AMC 1.5B
  • IPO Year
  • RCKT N/A
  • AMC 2013
  • Fundamental
  • Price
  • RCKT $2.95
  • AMC $2.95
  • Analyst Decision
  • RCKT Buy
  • AMC Hold
  • Analyst Count
  • RCKT 13
  • AMC 7
  • Target Price
  • RCKT $18.50
  • AMC $3.92
  • AVG Volume (30 Days)
  • RCKT 4.3M
  • AMC 8.4M
  • Earning Date
  • RCKT 08-04-2025
  • AMC 08-01-2025
  • Dividend Yield
  • RCKT N/A
  • AMC N/A
  • EPS Growth
  • RCKT N/A
  • AMC N/A
  • EPS
  • RCKT N/A
  • AMC N/A
  • Revenue
  • RCKT N/A
  • AMC $4,548,300,000.00
  • Revenue This Year
  • RCKT N/A
  • AMC $8.36
  • Revenue Next Year
  • RCKT N/A
  • AMC $6.63
  • P/E Ratio
  • RCKT N/A
  • AMC N/A
  • Revenue Growth
  • RCKT N/A
  • AMC N/A
  • 52 Week Low
  • RCKT $2.19
  • AMC $2.45
  • 52 Week High
  • RCKT $26.98
  • AMC $5.76
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 41.69
  • AMC 44.38
  • Support Level
  • RCKT $2.40
  • AMC $2.95
  • Resistance Level
  • RCKT $2.70
  • AMC $3.14
  • Average True Range (ATR)
  • RCKT 0.21
  • AMC 0.10
  • MACD
  • RCKT 0.15
  • AMC -0.03
  • Stochastic Oscillator
  • RCKT 73.53
  • AMC 36.36

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

Share on Social Networks: